[1]Chandra A, Pius C, Nabeel M, et al. Ovarian cancer: current status and strategies for improving therapeutic outcomes [J]. Cancer Med, 2019, 8(16): 7018-7031.
[2]Katopodis P, Chudasama D, Wander G, et al. Kinase inhibitors and ovarian cancer [J]. Cancers (Basel), 2019, 11(9): 1357.
[3]Richardson DL. New and novel therapies for gynecologic cancers [J]. Semin Oncol Nurs, 2019, 35(2): 217-219.
[4]RomaRodrigues C, Mendes R, Baptista PV, et al. Targeting tumor microenvironment for cancer therapy[J]. Int J Mol Sci, 2019, 20(4): 840.
[5]Wu S, Zheng Q, Xing X, et al. Matrix stiffnessupregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist premetastatic niche formation [J]. J Exp Clin Cancer Res, 2018, 37(1): 99.
[6]张鑫,江梦颖,张欣怡,等.外泌体与乳腺癌耐药的研究进展[J].临床医学,2020,40(8):118-122.
[7]Giraldo NA, SanchezSalas R, Peske JD, et al. The clinical role of the TME in solid cancer[J]. Br J Cancer, 2019, 120(1): 45-53.
[8]Rani S, Ryan AE, Griffin MD, et al. Mesenchymal stem cellderived extracellular vesicles: toward cellfree therapeutic applications[J]. Mol Ther, 2015, 23(5): 812-823.
[9]Ko SF, Yip HK, Zhen YY, et al. Adiposederived mesenchymal stem cell exosomes suppress hepatocellular carcinoma growth in a rat model: apparent diffusion coefficient, natural killer Tcell responses, and histopathological features [J]. Stem Cells Int, 2015, 2015: 853506.
[10]朱伟,张慧,黄蓓,等.间质干细胞和肿瘤[J].江苏大学学报(医学版),2006,16(3):265-267.
[11]Lu JH, Wei HJ, Peng BY, et al. Adiposederived stem cells enhance cancer stem cell property and tumor formation capacity in lewis lung carcinoma cells through an interleukin6 paracrine circuit [J]. Stem Cells Dev, 2016, 25(23): 1833-1842.
[12]Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis [J]. J Mol Med (Berl), 2013, 91(4): 431-437.
[13]Takebe N, Miele L, Harris PJ, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update [J]. Nat Rev Clin Oncol, 2015, 12(8): 445-464.
[14]Zhu W, Huang L, Li Y, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo[J]. Cancer Lett, 2012, 315(1): 28-37.
[15]Zhou X, Li T, Chen Y, et al. Mesenchymal stem cellderived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway [J]. Int J Oncol, 2019, 54(5): 1843-1852.
[16]Tang YT, Huang YY, Li JH, et al. Alterations in exosomal miRNA profile upon epithelialmesenchymal transition in human lung cancer cell lines [J]. BMC Genomics, 2018, 19(1): 802.
[17]Liang X. EMT: new signals from the invasive front [J]. Oral Oncol, 2011, 47(8): 686-687.
[18]Wang J, Ren D, Sun Y, et al. Inhibition of PLK4 might enhance the antitumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway [J]. J Cell Mol Med, 2020, 24(7): 3931-3947.
[19]Sun K, Luo J, Guo J, et al. The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review [J]. Osteoarthritis Cartilage, 2020, 28(4): 400-409.
[20]Wang L, Bo X, Yi X, et al. Exosometransferred LINC01559 promotes the progression of gastric cancer via PI3K/AKT signaling pathway [J]. Cell Death Dis, 2020, 11(9): 723.
[21]Gu H, Ji R, Zhang X, et al. Exosomes derived from human mesenchymal stem cells promote gastric cancer cell growth and migration via the activation of the Akt pathway [J]. Mol Med Rep, 2016, 14(4): 3452-3458.
|